Precision AQ is a commercialization partner for pharmaceutical and biotech companies, helping clients navigate product launches and label expansions across the entire lifecycle. The firm's services span value and access strategy, medical communications, investor relations, brand strategy and marketing, and data solutions. Its team of over 1,200 experts globally includes former access decision-makers, clinicians, scientists, strategists, and communications professionals.
The company supports biopharma innovators, market access leaders, and brand strategists with integrated technology and data solutions. Precision AQ has supported launches and label expansions for a significant portion of FDA-approved drugs, reflecting its reach across the industry. The firm operates at the intersection of data and human insight - a convergence it describes as where IQ meets EQ.